Sentiment Summary
Recent Events
Ex-dividend date for the 2025 final dividend of 144.08 Hong Kong cents per share, which was announced on March 19, 2026, is scheduled for May 28, 2026. Low importance is estimated as ex-dividend adjustments typically impact price by 1-2%, scheduled.
Tencent's final dividend of HKD 5.30 per share for fiscal year 2025 with the ex-dividend date on May 15, 2026, is estimated to have a medium price impact of over 5% and is scheduled.
Q1 2026 earnings release scheduled for 2026-05-06. This scheduled release is estimated to have a Low impact as a routine financial update, with analysts forecasting non-GAAP EPS between $1.10 and $1.17 forecasted.
Microsoft is scheduled to announce its fiscal year 2026 third-quarter earnings results on 2026-04-29. Importance is estimated as High based on typical market reaction to earnings expected
First quarter 2026 earnings results are scheduled to be released on April 29, 2026. The release is estimated to have a price impact of ~5%, scheduled.
MKS Inc. is scheduled to announce its Q1 2026 earnings on 2026-04-28. Analysts forecast a non-GAAP EPS of around $2.00, estimated. Medium importance is estimated as earnings typically drive 5-10% price volatility, scheduled.
Tesla's Q1 2026 earnings release, with low importance estimated based on typical quarterly price volatility, is scheduled.
The board of directors is scheduled to meet on March 31, 2026, to approve the annual results for the year ended December 31, 2025, and consider the payment of a final dividend, with the full earnings report expected. High importance is estimated due to the potential for a price impact of 10% or more, expected.
High importance estimated due to the significant 28% dividend increase, which is expected to result in a price impact of 10% or more. Quarterly dividend increased by 28% to $2.00 per share, announced on Feb 5, 2026. The ex-dividend date is March 31, 2026 scheduled.
Announced fiscal year 2025 results, with revenue of RMB 6.83 billion (+3.5% YoY) and net profit of RMB 888 million (+119.2% YoY). A final dividend of RMB 1.26 per 10 shares was proposed. High importance justified by significant profit growth likely causing >=10% price impact, expected.
FY2025 results announcement scheduled for 2026-03-30: revenue of CNY 1.66 billion (-17.9% YoY) and net profit of CNY 298 million (+302.1% YoY). The profit growth was driven by fair value gains on biological assets, while the core lab services business recorded a loss. High importance estimated due to significant profit volatility likely causing >10% price impact. expected
2025 annual results announcement on 2026-03-30, with net profit attributable to shareholders decreasing by 6%-10% year-over-year and a proposed final dividend of RMB 2.0 per 10 shares expected. A 6-10% profit decline is estimated to have a medium price impact.
Announced winning the "Biologics CDMO of the Year" (Large CDMOs) in the 2026 CDMO Leadership Awards for the ninth consecutive year. Low importance estimated as awards typically have minimal immediate price impact, scheduled.
Board nomination of Mr. Zhou Fengyuan as a non-executive director on 2026-03-30, subject to shareholder approval. Low importance estimated as routine board nominations usually have minimal price impact. scheduled
ZTE management detailed its strategy to counter rising costs and focus on AI smartphones during the 2025 annual results presentation on March 30, 2026; a low price impact is estimated as this is a strategic update, scheduled.
Announced a deepened cooperation agreement with Shouer Pharmaceutical on March 29, 2026, to enhance the accessibility of children's medicines and health products by leveraging JD Health's digital platform and supply chain; low importance reflects a typical strategic partnership with an estimated ≥1% price impact, scheduled.
Announced full-year 2025 financial results, reporting a net profit of approximately RMB 710 million and an 89.5% revenue increase to RMB 3.24 billion. High importance estimated due to the significant financial turnaround from a loss of RMB 1.47 billion, expected.
CEO Nikesh Arora purchased approximately $10 million worth of company stock in an open-market transaction on March 27, 2026. This is estimated to have a high impact (>=10%) as analysts view it as a strong bullish signal following a recent price decline, estimated.
Tencent's 2026 AI evolution roadmap and agentic AI product release including 'WorkBuddy' at the Cloud City Summit on March 27, 2026, is estimated to have a medium price impact of over 5% and is scheduled.
Announced the initiation of a Phase II multi-center clinical study for injectable drug JS212 on March 26, 2026; Low importance estimated as clinical progress typically has a minor price impact, scheduled.
ZTE's Chairman announced plans to release a 'Lobster' smartphone focusing on data security at the Boao Forum for Asia on March 26, 2026; a low price impact is estimated for this product announcement, scheduled.
Kuaishou announced its Q4 and full-year 2025 financial results on March 25, 2026. Full-year 2025 adjusted net profit increased by 16.5% year-over-year to RMB 20.6 billion, and revenue grew 12.5% to RMB 142.8 billion. A price impact of 10% or more is expected.
The company announced its intention to invest up to $100 million in the United Kingdom to accelerate quantum computing development, its first major planned investment outside of the US.
The company's registered capital was increased from approximately 470 million RMB to approximately 500 million RMB on March 25, 2026, following shareholder approval at an EGM on March 19, 2026.
Microsoft announced a major reorganization of its human resources department on 2026-03-25 to better align with the company's AI-first strategy, which included the departure of its Chief Diversity Officer.
Announced audited annual results for the year ended Dec 31, 2025. Revenue increased 16.7% YoY to RMB 21.8 billion, and net profit attributable to owners of the company increased 46.3% YoY to RMB 4.9 billion. High importance estimated due to significant profit growth, expected.
Announced the signing of a lease for a new 149,300 square foot headquarters in Santa Clara on 2026-03-24. This lease agreement is estimated to have a Low impact as it is a routine operational expansion, and occupancy is expected to begin in April 2027 expected.